• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session

    11/11/22 12:48:50 PM ET
    $AA
    $ACB
    $AGBA
    $AIRS
    Aluminum
    Industrials
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AA alert in real time by email

    Gainers

    • Snail, Inc. (NASDAQ:SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
    • AGBA Acquisition Limited (NASDAQ:AGBA) gained 70% to $9.35 after dipping 50% on Thursday. AGBA Acquisition announced approval of business combination and ability of stockholders to withdraw ordinary shares tendered for redemption.
    • Compass, Inc. (NYSE:COMP) surged 56% to $3.80. Compass posted a wider-than-expected loss for its third quarter, while sales topped estimates.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) jumped 39% to $0.6994 afetr dropping 26% on Thursday.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) gained 35.8% to $0.5092.
    • TransAct Technologies Incorporated (NASDAQ:TACT) surged 33% to $5.55 after the company swung to a profit for the third quarter.
    • 8i Acquisition 2 Corp. (NASDAQ:LAX) jumped 31.8% to $7.26 after dropping 43% on Thursday.
    • Telos Corporation (NASDAQ:TLS) gained 31.2% to $4.58.
    • Kalera Public Limited Company. (NASDAQ:KAL) climbed 31% to $0.1061 after gaining 10% on Thursday. Kalera recently said it sees Q3 net sales of $1.6 million.
    • Kaleyra, Inc. (NYSE:KLR) gained 30% to $0.8446. Kaleyra extended Oracle partnership to leverage Oracle Cloud.
    • uCloudlink Group Inc. (NASDAQ:UCL) rose 29.9% to $1.65. uCloudlink Group is expected to report Q3 financial results on November 16, 2022.
    • Sono Group N.V. (NASDAQ:SEV) gained 29.6% to $1.4650.
    • Sight Sciences, Inc. (NASDAQ:SGHT) shares gained 29.4% to $10.82 after the company posted upbeat Q3 sales and raised FY22 revenue outlook.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) surged 27.1% to $7.89. Avadel Pharmaceuticals posted a Q3 loss of $0.33 per share.
    • Versus Systems Inc. (NASDAQ:VS) jumped 26% to $3.7813 after jumping over 40% on Thursday. The company recently announced a 1-for-15 reverse stock split to aid compliance with Nasdaq listing requirements.
    • Doximity, Inc. (NYSE:DOCS) shares climbed 24.8% to $32.85 after the company reported better-than-expected Q2 results.
    • Tantech Holdings Ltd (NASDAQ:TANH) gained 23.6% to $2.88.
    • Century Aluminum Company (NASDAQ:CENX) gained 22.4% to $9.74. Century Aluminum recently posted a Q3 loss of $0.34 per share.
    • LifeMD, Inc. (NASDAQ:LFMD) jumped 21.6% to $2.53 following strong quarterly earnings.
    • Tuniu Corporation (NASDAQ:TOUR) climbed 21.5% to $0.84.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) gained 21.4% to $1.1899. GlycoMimetics recently posted a Q3 loss of $0.16 per share.
    • NanoString Technologies, Inc. (NASDAQ:NSTG) jumped 21.2% to $8.87. NanoString Technologies recently reported worse-than-expected Q3 results.
    • Agora, Inc. (NASDAQ:API) gained 20% to $3.65.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) jumped 19.9% to $1.81 following strong quarterly sales.
    • Zai Lab Limited (NASDAQ:ZLAB) gained 19.6% to $36.34. Zai Lab reported better-than-expected Q3 sales results.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) gained 19.4% to $5.45 after the company reported Q3 earnings results.
    • KE Holdings Inc. (NYSE:BEKE) rose 18.3% to $13.41 after gaining 9% on Thursday.
    • PDF Solutions, Inc. (NASDAQ:PDFS) gained 17.8% to $29.57 following better-than-expected quarterly results.
    • Matterport, Inc. (NASDAQ:MTTR) gained 17.5% to $3.56 after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
    • Aurora Cannabis Inc. (NASDAQ:ACB) jumped 17.2% to $1.5350. Aurora Cannabis reported Q1 sales of C$49.3 million.
    • GDS Holdings Limited (NASDAQ:GDS) rose 17% to $12.87 after climbing 20% on Thursday.
    • AvePoint, Inc. (NASDAQ:AVPT) jumped 16.4% to $4.61 following strong quarterly sales.
    • Cosmos Holdings Inc. (NASDAQ:COSM) gained 15% to $0.1322 after jumping around 58% on Thursday.
    • Beam Global (NASDAQ:BEEM) rose 14.8% to $14.98 after reporting Q3 results.
    • Alcoa Corporation (NYSE:AA) gained 14.7% to $50.35.
    • Piedmont Lithium Inc. (NASDAQ:PLL) gained 13.4% to $70.28.
    • Mister Car Wash, Inc. (NYSE:MCW) jumped 13.1% to $10.47 following strong quarterly results.
    • Redfin Corporation (NASDAQ:RDFN) gained 10.6% to $4.77.
    • Asana, Inc. (NYSE:ASAN) rose 8.3% to $20.35 after jumping 17% on Thursday.
    • Prudential plc (NYSE:PUK) shares rose 7.7% to $23.59 after gaining 7% on Thursday.
    • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) rose 7.4% to $0.43.


    Losers

    • Blue Apron Holdings, Inc. (NYSE:APRN) fell 31% to $1.1999. Blue Apron filed for offering of up to $30 million of common stock.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) dropped 29.2% to $3.35 after the company reported worse-than-expected Q3 results.
    • East Stone Acquisition Corporation (NASDAQ:ESSC) fell 28.1% to $7.17.
    • Fast Radius, Inc. (NASDAQ:FSRD) shares fell 27.8% to $0.1881. Fast Radius shares jumped 156% on Thursday after the company announced the United States Bankruptcy Court for the District of Delaware has approved all of the first-day motions related to the company's voluntary Chapter 11 petitions filed on November 7, 2022.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) shares fell 24.4% to $6.07 after the company issued 2022 sales guidance below estimates.
    • Science 37 Holdings, Inc. (NASDAQ:SNCE) dropped 24% to $0.95 after the company posted downbeat Q3 results and lowered sales guidance.
    • Entera Bio Ltd. (NASDAQ:ENTX) fell 22.4% to $0.48.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) dipped 21.8% to $0.4101. Aprea Therapeutics recently posted a Q3 loss of $0.12 per share.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) dropped 21.6% to $0.0816 after the company announced a 1-for-50 reverse stock split.
    • Rallybio Corporation (NASDAQ:RLYB) declined 19.5% to $5.39. Rallybio announced pricing of $50 million public offering of 5 million shares of common stock at a price of $6 per share.
    • Expensify, Inc. (NASDAQ:EXFY) dropped 19.2% to $10.46 after the company reported worse-than-expected Q3 EPS and sales results.
    • Ryan Specialty Holdings, Inc. (NYSE:RYAN) dropped 17.3% to $36.77 after the company reported worse-than-expected Q3 results. Multiple analysts lowered their price targets on the stock following the report.
    • FlexShopper, Inc. (NASDAQ:FPAY) fell 16.3% to $1.2794 after the company reported a year-over-year drop in Q3 sales.
    • Barfresh Food Group, Inc. (NASDAQ:BRFH) fell 16.3% to $1.4306. Barfresh reported Q3 sales of $2.4 million.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) shares fell 15.7% to $0.5201. RedHill Biopharma recently issued H1/22 highlights and Q3/22 estimates.
    • SHF Holdings, Inc. (NASDAQ:SHFS) dipped 15.3% to $3.21.
    • The Oncology Institute, Inc. (NASDAQ:TOI) dropped 15% to $2.4950. Guggenheim maintained The Oncology Institute with a Buy and lowered the price target from $7 to $6.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) fell 14.6% to $3.7550 after the company lowered its FY22 sales guidance below analyst estimates.
    • EverCommerce Inc. (NASDAQ:EVCM) dropped 13.9% to $7.14 after the company reported worse-than-expected Q3 results. Several analysts lowered their price targets on the stock following the report.
    • EpicQuest Education Group International Limited (NASDAQ:EEIQ) shares fell 12.9% to $1.56 after jumping 72% on Thursday.
    • ASP Isotopes Inc. (NASDAQ:ASPI) shares fell 11.6% to $2.3591 after dropping 33% on Thursday. ASP Isotopes announced $5 million pricing of initial public offering of 1.25m shares of common stock at a price of $4 per share.
    • GoHealth, Inc. (NASDAQ:GOCO) fell 8.2% to $0.4495 after posting downbeat Q3 sales.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ACB
    $AGBA
    $AIRS

    CompanyDatePrice TargetRatingAnalyst
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Compass Inc.
    $COMP
    1/27/2026$14.00Neutral
    Goldman
    Alcoa Corporation
    $AA
    1/27/2026$64.00Overweight → Equal-Weight
    Morgan Stanley
    Compass Inc.
    $COMP
    1/26/2026$15.00Overweight
    Analyst
    More analyst ratings

    $AA
    $ACB
    $AGBA
    $AIRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rubin Steven D bought $7,450 worth of Ordinary Shares (5,000 units at $1.49), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

    4 - Entera Bio Ltd. (0001638097) (Issuer)

    2/17/26 8:30:51 AM ET
    $ENTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $AA
    $ACB
    $AGBA
    $AIRS
    SEC Filings

    View All

    SEC Form 6-K filed by Prudential Public Limited Company

    6-K - PRUDENTIAL PLC (0001116578) (Filer)

    2/23/26 7:16:43 AM ET
    $PUK
    Life Insurance
    Finance

    SEC Form 15-12G filed by Avadel Pharmaceuticals plc

    15-12G - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)

    2/23/26 6:01:43 AM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Prudential Public Limited Company

    6-K - PRUDENTIAL PLC (0001116578) (Filer)

    2/20/26 6:50:16 AM ET
    $PUK
    Life Insurance
    Finance

    $AA
    $ACB
    $AGBA
    $AIRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Polestar Automotive Holding UK PLC downgraded by Cantor Fitzgerald

    Cantor Fitzgerald downgraded Polestar Automotive Holding UK PLC from Neutral to Underweight

    2/19/26 7:50:28 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Doximity upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00

    2/9/26 6:58:22 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    $AA
    $ACB
    $AGBA
    $AIRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy ser

    2/23/26 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

    CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has serve

    2/23/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Asana Now Available in the AWS Middle East (UAE) Region to Support Enterprise and Government Customers with Local Data Residency

    AI-powered work management platform now available with local data hosting and low-latency Asana, Inc. (NYSE:ASAN), a leading work management platform for human + AI collaboration, is now available in the AWS Middle East (UAE) Region. Asana is one of the first enterprise collaborative work management platforms to offer its services on AWS Marketplace. Its availability in the AWS Middle East (UAE) Region can help regulated and public sector organizations address data residency preferences. AI is accelerating how work gets done, but adoption depends on a strong foundation of trust, security, and governance. "We're seeing organizations across the Middle East modernize how they work—and

    2/22/26 11:00:00 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $AA
    $ACB
    $AGBA
    $AIRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Mackay Martin

    4 - Rallybio Corp (0001739410) (Issuer)

    2/20/26 6:08:28 PM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Hunt Ronald

    4 - Rallybio Corp (0001739410) (Issuer)

    2/20/26 5:50:52 PM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operations Officer Dziesietnik Sharon sold $26,971 worth of shares (19,687 units at $1.37), decreasing direct ownership by 4% to 446,736 units (SEC Form 4)

    4 - Brilliant Earth Group, Inc. (0001866757) (Issuer)

    2/20/26 5:12:35 PM ET
    $BRLT
    Consumer Specialties
    Consumer Discretionary

    $AA
    $ACB
    $AGBA
    $AIRS
    Financials

    Live finance-specific insights

    View All

    LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Conference ID:LIFEMDLive & Archived Webcast:Link   About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy ser

    2/23/26 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Century Aluminum Company Reports Fourth Quarter 2025 Results

    CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) today announced its fourth quarter and full year 2025 results. Fourth Quarter 2025 Highlights Net sales of $633.7 millionReported net income attributable to Century stockholders of $1.8 million, or $0.02 per diluted share; Adjusted net income attributable to Century stockholders of $128.2 million1, or $1.25 per share; Adjusted EBITDA attributable to Century stockholders of $170.6 million1Ending cash and cash equivalents of $134.2 million and strong liquidity of $418.0 million at December 31, 2025 Full Year 2025 Highlights Net sales of $2.5 billionReported net income attributable to Century stockholders of

    2/19/26 4:05:00 PM ET
    $CENX
    Aluminum
    Industrials

    a.k.a. Brands Holding Corp. to Report Fourth Quarter and Fiscal 2025 Financial Results on March 5, 2026

    a.k.a. Brands Holding Corp. (NYSE:AKA) (the "Company"), a portfolio of next generation fashion brands, today announced that it will report its fourth quarter and fiscal 2025 financial results after the market close on Thursday, March 5, 2026. The company will webcast a call with management that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). a.k.a. Brands' webcast will be available via the company website at ir.aka-brands.com. Analysts and investors may also call in on (877) 858-5495 or (201) 689-8853. A replay of the conference call will be available approximately three hours after the conclusion of the call on the company's website at ir.aka-brands.com or by dialing (877) 660-68

    2/19/26 8:00:00 AM ET
    $AKA
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AA
    $ACB
    $AGBA
    $AIRS
    Leadership Updates

    Live Leadership Updates

    View All

    The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

    CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has serve

    2/23/26 8:00:00 AM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones

    TEL AVIV, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that its Board of Directors has appointed Geno J. Germano as Chairman of the Board, effective February 4, 2026. Mr. Germano succeeds Gerald Lieberman, who is stepping down as Chairman. The appointment follows a period of accelerating progress across Entera's pipeline as the Company plans to advance two oral PTH peptide programs into clinical testing within 2026, a Phase 3 registrational study for EB613 in osteoporosis and a first-in-human study for Long-Acting Oral PTH in hypoparathyroidism. "

    2/9/26 8:50:09 AM ET
    $ENTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $ACB
    $AGBA
    $AIRS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ACB
    $AGBA
    $AIRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Beam Global

    SC 13G/A - Beam Global (0001398805) (Subject)

    12/6/24 4:12:03 PM ET
    $BEEM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Tuniu Corporation

    SC 13D/A - Tuniu Corp (0001597095) (Subject)

    12/6/24 6:30:27 AM ET
    $TOUR
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care